Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit?

Nephrology

Volumn 17, Issue 3, 2012, Pages 237-242

  Assimon, Magdalene M ^a   Salenger, Page V ^b   El Fawal, Hassan An ^a   Mason, Darius L ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b Hortenese and Louis Rubin Dialysis Center Inc   (United States)

Author keywords

adhesion molecule; endothelial dysfunction; ergocalciferol; haemodialysis; selectin

Indexed keywords

CARDIOLIPIN ANTIBODY; DOXERCALCIFEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ERGOCALCIFEROL; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; MALE; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; RACE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BETA 2-GLYCOPROTEIN I; DIETARY SUPPLEMENTS; ERGOCALCIFEROLS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; P-SELECTIN; PILOT PROJECTS; RENAL DIALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VITAMINS;

EID: 84857549672     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01555.x     Document Type: Article

References (35)

1. Collins AJ, Foley RN, Herzog C, et al,. United States Renal Data System 2008 Annual Data Report. Am. J. Kidney Dis. 2009; 53 (1 Suppl): S1-374.
2. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM,. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002; 62: 1524-38. (Pubitemid 35286260)
3. Ley K, Laudanna C, Cybulsky MI, Nourshargh S,. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007; 7: 678-89. (Pubitemid 47327397)
4. Huo Y, Xia L,. P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. Trends Cardiovasc. Med. 2009; 19: 140-45.
5. Carlos TM, Harlan JM,. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-101. (Pubitemid 24296363)
6. Kansas GS,. Selectins and their ligands: Current concepts and controversies. Blood 1996; 88: 3259-87. (Pubitemid 26365560)
7. Papayianni A, Alexopoulos E, Giamalis P, et al,. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: Association with inflammation, dyslipidaemia, and vascular events. Nephrol. Dial. Transplant. 2002; 17: 435-41. (Pubitemid 34211140)
8. Libby P,. Inflammation in atherosclerosis. Nature 2002; 420: 868-74. (Pubitemid 36019640)
9. Bevc S, Sabic S, Hojs R,. Atherosclerosis in hemodialysis patients-the role of microinflammation. Ren. Fail. 2008; 30: 1012-16.
10. Liakopoulos V, Eleftheriadis T, Kyropoulos T, et al,. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease. Ren. Fail. 2005; 27: 315-21. (Pubitemid 40770611)
11. Stenvinkel P, Lindholm B, Heimburger M, Heimburger O,. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol. Dial. Transplant. 2000; 15: 1624-30.
12. Kasahara J, Kobayashi K, Maeshima Y, et al,. Clinical significance of serum oxidized low-density lipoprotein/beta2-glycoprotein I complexes in patients with chronic renal diseases. Nephron Clin. Pract. 2004; 98: c15-24. (Pubitemid 39279375)
13. Papagianni A, Kalovoulos M, Kirmizis D, et al,. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol. Dial. Transplant. 2003; 18: 113-19. (Pubitemid 36104486)
14. Pierangeli SS, Harris EN,. Probing antiphospholipid-mediated thrombosis: The interplay between anticardiolipin antibodies and endothelial cells. Lupus 2003; 12: 539-45. (Pubitemid 36890147)
15. Marai I, Shechter M, Langevitz P, et al,. Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. Am. J. Cardiol. 2008; 101: 1094-7.
16. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW,. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin. Pract. 2007; 105: c132-8. (Pubitemid 46215207)
17. Achinger SG, Ayus JC,. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int. Suppl. 2005; 95: S37-42. (Pubitemid 43361555)
18. Tarcin O, Yavuz DG, Ozben B, et al,. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J. Clin. Endocrinol. Metab. 2009; 94: 4023-30.
19. Blair D, Byham-Gray L, Lewis E, McCaffrey S,. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J. Ren. Nutr. 2008; 18: 375-82. (Pubitemid 351818240)
20. Dobnig H, Pilz S, Scharnagl H, et al,. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 2008; 168: 1340-49. (Pubitemid 351930842)
21. Ibi M, Sawada H, Nakanishi M, et al,. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001; 40: 761-71. (Pubitemid 32436453)
22. Martinesi M, Bruni S, Stio M, Treves C,. 1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. Cell Biol. Int. 2006; 30: 365-75.
23. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C,. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res. Clin. Pract. 2007; 77: 47-57. (Pubitemid 46590467)
24. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD,. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008; 25: 320-25. (Pubitemid 351322698)
25. Al-Badr W, Martin KJ,. Vitamin D and kidney disease. Clin. J. Am. Soc. Nephrol. 2008; 3: 1555-60.
26. Jean G, Terrat JC, Vanel T, et al,. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: Evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin. Pract. 2008; 110: c58-65.
27. Dusso AS, Brown AJ, Slatopolsky E,. Vitamin D. Am. J. Physiol. Renal Physiol. 2005; 289: F8-28. (Pubitemid 40863568)
28. Holick MF,. Vitamin D for health and in chronic kidney disease. Semin. Dial. 2005; 18: 266-75. (Pubitemid 41159576)
29. Zehnder D, Bland R, Chana RS, et al,. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: A novel autocrine determinant of vascular cell adhesion. J. Am. Soc. Nephrol. 2002; 13: 621-9. (Pubitemid 34183926)
30. Talmor Y, Bernheim J, Klein O, Green J, Rashid G,. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur. J. Clin. Invest. 2008; 38: 548-54. (Pubitemid 352019134)
31. Motiwala SR, Wang TJ,. Vitamin D and cardiovascular disease. Curr. Opin. Nephrol. Hypertens. 2011; 20: 345-53.
32. Oh J, Weng S, Felton SK, et al,. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687-98.
33. Targher G, Bertolini L, Padovani R, et al,. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. (Oxf) 2006; 65: 593-7. (Pubitemid 44583818)
34. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD,. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J. Am. Soc. Nephrol. 2010; 21: 353-61.
35. Kandula P, Dobre M, Schold JD, Schreiber MJ, Jr, Mehrotra R, Navaneethan SD,. Vitamin D supplementation in chronic kidney disease: A systematic review and meta-analysis of observational studies and randomized controlled trials. Clin. J. Am. Soc. Nephrol. 2011; 6: 50-62.